1. MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression
    Juan Yang et al, 2016, Biomedicine & Pharmacotherapy CrossRef
  2. Rs9679162 genotype predicts prognosis of real-world advanced hepatocellular carcinoma treated by sorafenib
    Chih-Lang Lin et al, 2023, Cancer Biomarkers CrossRef
  3. Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer
    Jing Zhang et al, 2021, Protein & Cell CrossRef
  4. GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma
    Yung-Kuan Tsou et al, 2017, Oncotarget CrossRef
  5. GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells
    Yu-De Chu et al, 2022, Cell Death & Disease CrossRef
  6. A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
    Chih-Lang Lin et al, 2023, International Journal of Molecular Sciences CrossRef
  7. The GALNT14 Genotype Predicts Postoperative Outcome of Pancreatic Ductal Adenocarcinoma
    Chun-Cheng Chiang et al, 2019, Journal of Clinical Medicine CrossRef
  8. Early Alpha-Fetoprotein Response Is Associated With Survival in Patients With HBV-Related Hepatocellular Carcinoma Receiving Lenvatinib
    Bo Liu et al, 2022, Frontiers in Oncology CrossRef
  9. GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
    Wey-Ran Lin et al, 2020, International Journal of Molecular Sciences CrossRef
  10. Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature review
    Wen-Chi Chou et al, 2018, Journal of the Formosan Medical Association CrossRef
  11. GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma
    Kung-Hao Liang et al, 2017, Oncology Letters CrossRef
  12. GALNT14 Genotype Effectively Predicts The Therapeutic Response in Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization
    Kung-Hao Liang et al, 2016, Pharmacogenomics CrossRef
  13. GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy
    Wey-Ran Lin et al, 2016, Medicine CrossRef
  14. Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
    Kung-Hao Liang et al, 2021, Biomedicines CrossRef